Home›Companies›Biotech & Pharma›AbbraTech

AbbraTech Holdings LLC

Develops antibody discovery technology for industry and academic research partners.

Updated Nov 20, 2026·Latest SEC filing Dec 6, 2023·Suggest an edit

About AbbraTech

AbbraTech is a private company based in Branford, Connecticut, incorporated in 2023 in Delaware. It has reported $8,505,834 raised in one offering on Form D since December 2023. Its chief executive is Michael Weiner.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 27, 2023Dec 6, 2023$8,505,834of $9.9M target17$500KEquity, Options, Securities on exerciseRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on AbbraTech's Form D filed Dec 6, 2023.

MW
Michael Weiner
Founder & CEO, director
Sean Cassidy
Sean Cassidy
Board of Directors Member
Michael Egholm
Michael Egholm
Board of Directors Member
Kenan Turnacioglu
Kenan Turnacioglu
Board of Directors Member
Kenan Turnacioglu appears on 8 Form D filings at 3 companies:
  • Paige, director: Nov 27, 2019 · Jul 14, 2020 (amended) · Jan 27, 2021 · Mar 17, 2023
  • AbbraTech, board of directors member: Dec 6, 2023
  • Sentonix, executive officer and director: Oct 3, 2024 · May 12, 2025 (amended) · Aug 20, 2026
Sean Mackay
Sean Mackay
Board of Directors Member

Sources

  1. SECAbbraTech Holdings LLC filing history
  2. CompanyMeet our team